Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

• Autors principals: Steven H Abman (Autor), Nicholas R Fox (Autor), M Ibrahim Malik (Autor), Sneha S Kelkar (Autor), Shelby L Corman (Autor), Sanika Rege (Autor), Jenna Bhaloo (Autor), Rachel Shah (Autor), Ren-Jay Shei (Autor), Dana Saporito (Autor), Nisreen Shamseddine (Autor), Erik DeBoer (Autor), George J Wan (Autor), on behalf of the NOTICE Study Investigators (Autor)
• Format: Llibre
• Publicat: BioExcel Publishing Ltd, 2022-04-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Inhaled nitric oxide (iNO) has been studied in patients with severe acute respiratory distress syndrome (ARDS) due to COVID-19 when it may be too late to impact disease course. This article aims to describe real-world iNO use and outcomes in patients with COVID-19 with mild-to-moderate A...